Global Bioburden Testing Research Report: By Test Type (Aerobic Count, Anaerobic Count, and others), by Product Type (Consumables, Instruments), by Application (Raw Materials Testing, Medical Devices Testing, and others), by End-User - Forecast Till 2023
Bioburden Testing Market - Highlights
The Global Bioburden Testing Market is expected to register a CAGR of Approx. 9.15% during the forecast period of 2018–2023 with an estimated market value of USD 455 million. Bioburden testing refers to an estimation of microbial load on a medical instrument, raw material, packaged goods among others. Several factors such as rising medical spending, increasing food safety concerns and growing product recalls due to microbial contamination are projected to drive the growth of the market. On the other hand, high costs of microbial enumeration instruments and complex and time-consuming regulatory standards in some economies may curb the market growth during the assessment period. Moreover, test reports and certificates tend to be different from one country to another which hampers international trade. Therefore, in December 2017, International Organization for Standardization (ISO) published a new edition of ISO/IEC 17025 standard. This standard is an international reference for laboratories carrying out calibration and testing activities around the world. ISO/IEC 17025 helps facilitate cooperation between laboratories and other bodies by creating widespread acceptance of results between countries.
The global bioburden testing market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in October 2018, Becton, Dickinson and Company, a leading global medical technology company, announced the availability of the BD MAX MDR-TB (multi-drug resistant tuberculosis) panel in Europe.
Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6716
Regional Analysis:
The market in the Americas is expected to dominate the global bioburden testing market during the forecast period owing to the presence of well-established healthcare system, increasing healthcare expenditure, and favorable reimbursement scenario. The European market is expected to be the second-largest due to availability of funds for research from public and private sources. Moreover, the market in Asia-Pacific is predicted to be the fastest-growing during the assessment period owing to growing disposable income, and continuously developing economies. The market in the Middle East & Africa is likely to account for the smallest share of the global bioburden testing market. The market growth in this region can be attributed to the growing government initiatives.
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Manufacturers of Food and Beverage Products
- Diagnostic Laboratories
- Manufacturers of Agricultural Products
- Government Research Institutes
- Academic Institutes and Universities
Segmentation:
The global bioburden testing market has been segmented into test type, product type, application and end-user.
The market, on the basis of type, has been segmented into aerobic count, anaerobic count, fungi count and spore count.
The market, on the basis of product type, has been segmented into consumables and instruments.
The market, by consumables, has been sub-segmented into reagents and kits, and others.
The market, by instruments, has been further segmented into polymerase chain reaction machine (PCR), microscopes, and others.
The market, by application, has been segmented into raw materials testing, medical devices testing, in-process material testing, sterilization validation testing, and equipment cleaning validation.
The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, microbial testing laboratories, and others.
Access Report Details @ https://www.marketresearchfuture.com/reports/bioburden-testing-market-6716
Global Market – Competitive Dashboard
Some of the key players in the global bioburden testing market are WuXi AppTec, Charles River, SGS SA, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Phone: +1 646 845 9312
Email: [email protected]
The Bioburden Testing Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the bioburden testing market include Becton, Dickinson and Company, bioMérieux S.A., Charles River, Merck KGaA, NAMSA, Nelson Laboratories, LLC, Pacific BioLabs, SGS SA, Thermo Fisher Scientific, Inc. and WuXi App Tec.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Bioburden Testing Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/bioburden-testing-market/download-sampleMarket DynamicsThe rapidly growing healthcare industry along with the technological advancements is primarily driving the market growth.
In addition to this, rising safety concern globally is further expected to boost market growth.
On the flip side, the high cost of laboratory instruments may limit market growth.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
